Optimized indirect ELISA conditions identified after deployment of the chessboard titration method were used to determine the IgG and IgA antibody levels of CRC patients and their case-matched clinically healthy controls against ETBF. The gene discussed is CD79A; the disease is colorectal carcinoma.